Episodes

Friday Nov 22, 2024
ACR24 - Day4c
Friday Nov 22, 2024
Friday Nov 22, 2024
Is Frequent Lab Monitoring Necessary?:Dr. Bella Mehta
The Case for JAKi in PMR:Dr. David Liew
Treatment Strategies in RA:Dr. Victoria Konzett
What's New in Relapsing Polychondritis?:Dr. Bella Mehta
Worried about CV Risk and JAKi? What about the Steroids?:Dr. David Liew

Wednesday Nov 20, 2024
ACR24 - Day4b
Wednesday Nov 20, 2024
Wednesday Nov 20, 2024
ANCA Vasculitis "Eye": Can rituximab help?:Dr. Janet Pope
Apremilast in PsA: Results from Mosaic Trial:Dr. Guillermo Valenzuela
Implantable Vagus Nerve Stimulator for RA:Dr. Guillermo Valenzuela
Treat-to-Target Improves Fertility in Women with RA:Dr. Richard Conway

Wednesday Nov 20, 2024
RheumNow Day 4 Recap ACR Convergence 2024 Highlights
Wednesday Nov 20, 2024
Wednesday Nov 20, 2024
Catch the latest insights from the ACR Annual Meeting, where leading experts share groundbreaking research and clinical advances in rheumatology. Don’t miss our live coverage of key takeaways and trends shaping the future of patient care.
Join us live and stay at the forefront of rheumatology!

Tuesday Nov 19, 2024
ACR24 - Day4a
Tuesday Nov 19, 2024
Tuesday Nov 19, 2024
ACR 24: What I learned in Sjogren's, Takayasu's and CAR-T:Dr. Janet Pope
Anti IL-17 on Entheseal Biopsy in PsA:Dr. Eric Dein
axSpA: Impact of TNF and IL-17 in Patients with Prior TNF Exposure:Dr. Brian Jaros
Can We Make Clinical Trials Better?:Dr. Janet Pope
Cumulative Steroid Use and Cardiovascular Events:Dr. Mrinalini Dey
IL 6 Inhibitors, Frailty and Polymyalgia Rheumatica:Drs. Trish Harkins and Sebastian Sattui
IVIG Treatment in Immune-mediated Necrotizing Myopathy:Drs. Caoilfhionn Connolly interviews Dr. Asim Mohamed
Machine Learning for Predicting Flares in axSpA:Dr. Sheila Reyes
So really, are JAKs Safe?:Dr. Janet Pope
Tackling the Workforce Crisis: A shared dilemma:Drs. Mrinalini Dey, Louise Pollard and Bharat Kumar
The 2024 ACR Guidelines for Lupus Nephritis:Dr. Sheila Reyes
The Real Value of JAKi is Beyond RA:Dr. David Liew
Vaccine Responses:The DMARD Counts:Dr. David Liew

Tuesday Nov 19, 2024
RheumNow Day 3 Recap ACR Convergence 2024 Highlights
Tuesday Nov 19, 2024
Tuesday Nov 19, 2024
Catch the latest insights from the ACR Annual Meeting, where leading experts share groundbreaking research and clinical advances in rheumatology. Don’t miss our live coverage of key takeaways and trends shaping the future of patient care.
Join us live and stay at the forefront of rheumatology!

Monday Nov 18, 2024
ACR24 -Day3b
Monday Nov 18, 2024
Monday Nov 18, 2024
Best Things I Saw Today in PsA:Dr. Catherine Bakewell
Do TNFis and JAKis Prevent Cancer!?:Dr. Richard Conway
Efficacy and Safety of Nipocalimab for Sjogren's Syndrome:Dr. Mike Putman
Evaluating ANA Patterns and Titers with AI:Dr. Bella Mehta
Improvements in Pain and Fatigue in Bimekizumab:Dr. Philip Mease
Long Term Follow up from APIPPRA:Dr. Antoni Chan talks with Dr. Andrew Cope
Race Neutral PFTs in Scleroderma Improves Equity:Dr. Caoilfhionn Connolly talks with Dr. Kamini Kuchinad
Summary of JAKi Studies:Dr. Peter Nash
The Psoriatic March: PsA before PsO:DR. Antoni Chan
Use of AI in Hand Ultrasound Scoring:Dr. Bella Mehta
What is MCTD? The Great Debate:Drs. Caoilfhionn Connolly & Lisa Christopher-Stine
What's The State of Biosimilars?:Drs. Eric Dein and Jonathan Kay
Pred Softly: Steroids:Dr. Jiha Lee talks with Dr. Beth Wallace

Monday Nov 18, 2024
ACR24 - Day3a
Monday Nov 18, 2024
Monday Nov 18, 2024
Control RA, Build Stronger Bones:Dr. Jiha Lee talks with Dr. Rachel Elam
Hold or continue JAKi and IL-17 when receiving COVID boosters?:Dr. Bella Mehta
Long-term Safety Profile of Bimekizumab in axSpA and PsA:Dr. Philip Mease
Navigating Rheumatology Care in Humanitarian Crisis Settings:Dr. Antoni Chan talks with Dr. Martha Dhzhus
RA Roundup: Is LDA Inappropriate? What about Statins for JAKs?:Dr. Eric Dein
Sex Differences in Psoriatic Arthritis:Dr. Catherine Bakewell
Single v Double Lung Transplants for Disease-related ILD:Dr. Eric Dein talks with Dr. Harry Hurley
Sonelokimab in PsA: Phase 2 Data:Dr. Philip Mease
Treating SpA:Dr. Marina Magrey

Monday Nov 18, 2024
ACR24 - Day2d
Monday Nov 18, 2024
Monday Nov 18, 2024
Assessment of axSpA:Dr. Antoni Chan
Defining Difficult to Manage axSpA:Dr. Lihi
DISH in SpA:Dr. Sheila Reyes
Generative AI in Rheumatology: The Good, The Bad, The Ugly:Dr. Akhil Sood
Native Americans with RA Die Young:Dr. Eric Dein
Precision Immunotherapy in Axial SpA:Dr. Marina Magrey
When, What and How Long to Treat GCA & PMR:Dr. Janet Pope

Monday Nov 18, 2024
ACR24 - Day2c
Monday Nov 18, 2024
Monday Nov 18, 2024
A Fibroblast Renaissance:Dr. Andrea Fava
A useful urinary biomarker for lupus nephritis:Dr. Andrea Fava
ACR Advocacy Update:Dr. Eric Dein talks with Dr. Christina Downey, ACR Government Affairs Committee, and Dr. Kaitlyn Brittan, RheumPAC
Carotid Doppler Ultrasound Screening in Axial SpA:Dr. Trish Harkins discussed with Dr. Barry O'Shea
Enhanced Detection of Myocarditis in Idiopathic Inflammatory
Myopathies:Dr. Caoilfhionn Connolly talks with Dr. Julie Paik
PsA: Impact of Sex:Dr. Arthur Kavanaugh
Rethinking Lupus Care: Early Biologics, Less Steroids:Dr. Akhil
Treatment Considerations for RA-ILD:Dr. Jeff Sparks with Dr. Scott Matson

Monday Nov 18, 2024
ACR24 Daily Recap Day2
Monday Nov 18, 2024
Monday Nov 18, 2024
Catch the latest insights from the ACR Annual Meeting, where leading experts share groundbreaking research and clinical advances in rheumatology. Don’t miss our live coverage of key takeaways and trends shaping the future of patient care.
Join us live and stay at the forefront of rheumatology!
